Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: A longitudinal study

Sheila K West, Beatriz Munoz, Harran Mkocha, Martin J. Holland, Aura Aguirre, Anthony W. Solomon, Allen Foster, Robin L. Bailey, David C W Mabey

Research output: Contribution to journalArticle

Abstract

Background: Data from studies done in communities where trachoma is mesoendemic suggest that ocular infection with Chlamydia trachomatis can be eliminated after one mass treatment with antibiotics. However, there are no comparable long-term data from trachoma hyperendemic communities. Our aim, therefore, was two-fold: first, to ascertain the disease pattern of trachoma and ocular infection with C trachomatis in a trachoma hyperendemic community after mass treatment; and, second, to ascertain the risk factors for incident infection. Methods: We did a longitudinal study of a trachoma hyperendemic community (n=1017) in Tanzania. We did surveys, including ocular swabs, at baseline, 2, 6, 12, and 18 months to identify the presence, and quantity, of C trachomatis after single mass treatment of all individuals aged 6 months or older with azithromycin 20 mg per kg; pregnant women without clinical disease received topical tetracycline. Findings: Mass treatment (coverage 86%) significantly reduced the prevalence of infection from 57% (495 of 871) to 12% (85 of 705) at 2 months. Infection remained fairly constant to 12 months, with evidence of increasing numbers and load of infection by 18 months post-treatment. Incident infection at 6 months was 3·5-times more likely if another member of the household had more than 19 organisms per swab at 2 months. Travel outside the village, and visitors to the household, did not increase the risk of infection within households up to 12 months. Interpretation: In this trachoma hyperendemic community, infection levels after high antibiotic coverage persisted at a low level to 18 months, with evidence for re-emergence after 1 year. Fairly light loads of infection were associated with household transmission. Yearly mass treatment over a few years could be sufficient to eliminate infection.

Original languageEnglish (US)
Pages (from-to)1296-1300
Number of pages5
JournalThe Lancet
Volume366
Issue number9493
DOIs
StatePublished - Oct 8 2005

Fingerprint

Trachoma
Tanzania
Chlamydia trachomatis
Longitudinal Studies
Infection
Eye Infections
Therapeutics
Anti-Bacterial Agents
Azithromycin
Tetracycline
Pregnant Women

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania : A longitudinal study. / West, Sheila K; Munoz, Beatriz; Mkocha, Harran; Holland, Martin J.; Aguirre, Aura; Solomon, Anthony W.; Foster, Allen; Bailey, Robin L.; Mabey, David C W.

In: The Lancet, Vol. 366, No. 9493, 08.10.2005, p. 1296-1300.

Research output: Contribution to journalArticle

West, Sheila K ; Munoz, Beatriz ; Mkocha, Harran ; Holland, Martin J. ; Aguirre, Aura ; Solomon, Anthony W. ; Foster, Allen ; Bailey, Robin L. ; Mabey, David C W. / Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania : A longitudinal study. In: The Lancet. 2005 ; Vol. 366, No. 9493. pp. 1296-1300.
@article{f08ae844ac094962bd7fa25c7b363dfc,
title = "Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: A longitudinal study",
abstract = "Background: Data from studies done in communities where trachoma is mesoendemic suggest that ocular infection with Chlamydia trachomatis can be eliminated after one mass treatment with antibiotics. However, there are no comparable long-term data from trachoma hyperendemic communities. Our aim, therefore, was two-fold: first, to ascertain the disease pattern of trachoma and ocular infection with C trachomatis in a trachoma hyperendemic community after mass treatment; and, second, to ascertain the risk factors for incident infection. Methods: We did a longitudinal study of a trachoma hyperendemic community (n=1017) in Tanzania. We did surveys, including ocular swabs, at baseline, 2, 6, 12, and 18 months to identify the presence, and quantity, of C trachomatis after single mass treatment of all individuals aged 6 months or older with azithromycin 20 mg per kg; pregnant women without clinical disease received topical tetracycline. Findings: Mass treatment (coverage 86{\%}) significantly reduced the prevalence of infection from 57{\%} (495 of 871) to 12{\%} (85 of 705) at 2 months. Infection remained fairly constant to 12 months, with evidence of increasing numbers and load of infection by 18 months post-treatment. Incident infection at 6 months was 3·5-times more likely if another member of the household had more than 19 organisms per swab at 2 months. Travel outside the village, and visitors to the household, did not increase the risk of infection within households up to 12 months. Interpretation: In this trachoma hyperendemic community, infection levels after high antibiotic coverage persisted at a low level to 18 months, with evidence for re-emergence after 1 year. Fairly light loads of infection were associated with household transmission. Yearly mass treatment over a few years could be sufficient to eliminate infection.",
author = "West, {Sheila K} and Beatriz Munoz and Harran Mkocha and Holland, {Martin J.} and Aura Aguirre and Solomon, {Anthony W.} and Allen Foster and Bailey, {Robin L.} and Mabey, {David C W}",
year = "2005",
month = "10",
day = "8",
doi = "10.1016/S0140-6736(05)67529-0",
language = "English (US)",
volume = "366",
pages = "1296--1300",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9493",

}

TY - JOUR

T1 - Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania

T2 - A longitudinal study

AU - West, Sheila K

AU - Munoz, Beatriz

AU - Mkocha, Harran

AU - Holland, Martin J.

AU - Aguirre, Aura

AU - Solomon, Anthony W.

AU - Foster, Allen

AU - Bailey, Robin L.

AU - Mabey, David C W

PY - 2005/10/8

Y1 - 2005/10/8

N2 - Background: Data from studies done in communities where trachoma is mesoendemic suggest that ocular infection with Chlamydia trachomatis can be eliminated after one mass treatment with antibiotics. However, there are no comparable long-term data from trachoma hyperendemic communities. Our aim, therefore, was two-fold: first, to ascertain the disease pattern of trachoma and ocular infection with C trachomatis in a trachoma hyperendemic community after mass treatment; and, second, to ascertain the risk factors for incident infection. Methods: We did a longitudinal study of a trachoma hyperendemic community (n=1017) in Tanzania. We did surveys, including ocular swabs, at baseline, 2, 6, 12, and 18 months to identify the presence, and quantity, of C trachomatis after single mass treatment of all individuals aged 6 months or older with azithromycin 20 mg per kg; pregnant women without clinical disease received topical tetracycline. Findings: Mass treatment (coverage 86%) significantly reduced the prevalence of infection from 57% (495 of 871) to 12% (85 of 705) at 2 months. Infection remained fairly constant to 12 months, with evidence of increasing numbers and load of infection by 18 months post-treatment. Incident infection at 6 months was 3·5-times more likely if another member of the household had more than 19 organisms per swab at 2 months. Travel outside the village, and visitors to the household, did not increase the risk of infection within households up to 12 months. Interpretation: In this trachoma hyperendemic community, infection levels after high antibiotic coverage persisted at a low level to 18 months, with evidence for re-emergence after 1 year. Fairly light loads of infection were associated with household transmission. Yearly mass treatment over a few years could be sufficient to eliminate infection.

AB - Background: Data from studies done in communities where trachoma is mesoendemic suggest that ocular infection with Chlamydia trachomatis can be eliminated after one mass treatment with antibiotics. However, there are no comparable long-term data from trachoma hyperendemic communities. Our aim, therefore, was two-fold: first, to ascertain the disease pattern of trachoma and ocular infection with C trachomatis in a trachoma hyperendemic community after mass treatment; and, second, to ascertain the risk factors for incident infection. Methods: We did a longitudinal study of a trachoma hyperendemic community (n=1017) in Tanzania. We did surveys, including ocular swabs, at baseline, 2, 6, 12, and 18 months to identify the presence, and quantity, of C trachomatis after single mass treatment of all individuals aged 6 months or older with azithromycin 20 mg per kg; pregnant women without clinical disease received topical tetracycline. Findings: Mass treatment (coverage 86%) significantly reduced the prevalence of infection from 57% (495 of 871) to 12% (85 of 705) at 2 months. Infection remained fairly constant to 12 months, with evidence of increasing numbers and load of infection by 18 months post-treatment. Incident infection at 6 months was 3·5-times more likely if another member of the household had more than 19 organisms per swab at 2 months. Travel outside the village, and visitors to the household, did not increase the risk of infection within households up to 12 months. Interpretation: In this trachoma hyperendemic community, infection levels after high antibiotic coverage persisted at a low level to 18 months, with evidence for re-emergence after 1 year. Fairly light loads of infection were associated with household transmission. Yearly mass treatment over a few years could be sufficient to eliminate infection.

UR - http://www.scopus.com/inward/record.url?scp=26244436818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26244436818&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(05)67529-0

DO - 10.1016/S0140-6736(05)67529-0

M3 - Article

C2 - 16214600

AN - SCOPUS:26244436818

VL - 366

SP - 1296

EP - 1300

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9493

ER -